Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA advisory committee
Fierce Biotech
FDA to end 9-month adcomm hiatus with review of AZ cancer drugs
The April 30 event is also the first ODAC meeting after longtime FDA oncology czar Richard Pazdur, M.D., suddenly retired in December.
Angus Liu
Mar 6, 2026 11:16am
Travere's bid to gain new approval for Filspari hits FDA hitch
Jan 14, 2026 11:22am
CDC documents reveal RFK Jr.'s 7 new ACIP nominees: reports
Sep 4, 2025 11:55am
RFK Jr. critic Paul Offit blocked from FDA vaccine panel
Sep 3, 2025 10:44am
Amgen's ChemoCentryx prevails in investor lawsuit
Aug 19, 2025 10:13am
Moderna, Otsuka-Lundbeck, Pfizer-3SBio—Fierce Pharma Asia
Jul 25, 2025 9:46am
